Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2001 1
2002 4
2005 2
2006 1
2007 1
2008 2
2010 3
2011 9
2012 2
2013 6
2014 6
2015 5
2016 5
2017 3
2018 3
2019 4
2020 8
2021 6
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

63 results
Results by year
Filters applied: . Clear all
Page 1
CBD, a precursor of THC in e-cigarettes.
Czégény Z, Nagy G, Babinszki B, Bajtel Á, Sebestyén Z, Kiss T, Csupor-Löffler B, Tóth B, Csupor D. Czégény Z, et al. Among authors: sebestyen z. Sci Rep. 2021 Apr 26;11(1):8951. doi: 10.1038/s41598-021-88389-z. Sci Rep. 2021. PMID: 33903673 Free PMC article.
Cave bacteria-induced amorphous calcium carbonate formation.
Enyedi NT, Makk J, Kótai L, Berényi B, Klébert S, Sebestyén Z, Molnár Z, Borsodi AK, Leél-Őssy S, Demény A, Németh P. Enyedi NT, et al. Among authors: sebestyen z. Sci Rep. 2020 May 26;10(1):8696. doi: 10.1038/s41598-020-65667-w. Sci Rep. 2020. PMID: 32457467 Free PMC article.
Identification of a tumor-specific allo-HLA-restricted γδTCR.
Kierkels GJJ, Scheper W, Meringa AD, Johanna I, Beringer DX, Janssen A, Schiffler M, Aarts-Riemens T, Kramer L, Straetemans T, Heijhuurs S, Leusen JHW, San José E, Fuchs K, Griffioen M, Falkenburg JH, Bongiovanni L, de Bruin A, Vargas-Diaz D, Altelaar M, Heck AJR, Shultz LD, Ishikawa F, Nishimura MI, Sebestyén Z, Kuball J. Kierkels GJJ, et al. Among authors: sebestyen z. Blood Adv. 2019 Oct 8;3(19):2870-2882. doi: 10.1182/bloodadvances.2019032409. Blood Adv. 2019. PMID: 31585951 Free PMC article.
Cancer Immunotherapy Using γδT Cells: Dealing with Diversity.
Scheper W, Sebestyen Z, Kuball J. Scheper W, et al. Among authors: sebestyen z. Front Immunol. 2014 Nov 20;5:601. doi: 10.3389/fimmu.2014.00601. eCollection 2014. Front Immunol. 2014. PMID: 25477886 Free PMC article. Review.
Adding Help to an HLA-A*24:02 Tumor-Reactive γδTCR Increases Tumor Control.
Johanna I, Hernández-López P, Heijhuurs S, Scheper W, Bongiovanni L, de Bruin A, Beringer DX, Oostvogels R, Straetemans T, Sebestyen Z, Kuball J. Johanna I, et al. Among authors: sebestyen z. Front Immunol. 2021 Oct 25;12:752699. doi: 10.3389/fimmu.2021.752699. eCollection 2021. Front Immunol. 2021. PMID: 34759930 Free PMC article.
Cost-effectiveness analysis of intensity-modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer.
Zemplényi AT, Kaló Z, Kovács G, Farkas R, Beöthe T, Bányai D, Sebestyén Z, Endrei D, Boncz I, Mangel L. Zemplényi AT, et al. Among authors: sebestyen z. Eur J Cancer Care (Engl). 2018 Jan;27(1). doi: 10.1111/ecc.12430. Epub 2016 Jan 19. Eur J Cancer Care (Engl). 2018. PMID: 26782759 Review.
63 results